1)日本肝癌研究会:第17回全国原発性肝癌追跡調査報告(2002~2003).日本肝癌研究会事務局,2006
2)日本肝癌研究会(編):臨床・病理―原発性肝癌取扱い規約,改訂第4版.金原出版,2001
3)科学的根拠に基づく肝癌診療ガイドライン作成に関する研究班(編):科学的根拠に基づく肝癌診療ガイドライン,2005年版.金原出版,2005
4)Matsui O, Kadoya M, Kameyama T, et al:Benign and malignant nodules in cirrhotic livers:Distinction based on blood supply. Radiology 178:493-497, 1991
5)Torzilli G, Minagawa M, Takayama T, et al:Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30:889-893, 1999
6)徳原 真,羽木裕雄,森 俊幸,他:肝細胞癌の画像診断―画像診断の進め方.消外 24:604-612,2001
7)Jang HJ, Lim JH, Lee SJ, et al:Hepatocellular carcinoma:Are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology 215:373-380, 2000
8)Kudo M:Contrast harmonic imaging in the diagnosis and treatment of hepatic tumors. Springer, Tokyo, 2003
9)Hatano E, Ikai I, Higashi T, et al:Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg 30:1736-1741, 2006
10)Seo S, Hatano E, Higashi T, et al:Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 13:427-433, 2007
11)Obi S, Yoshida H, Toune R, et al:Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106:1990-1997, 2006